Patents by Inventor Behnoush Khorsand-Sourkohi

Behnoush Khorsand-Sourkohi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210308326
    Abstract: Disclosed herein are compositions to facilitate bone growth, formation, and/or repair. Methods of using and making the compositions are also disclosed.
    Type: Application
    Filed: July 18, 2019
    Publication date: October 7, 2021
    Inventors: Aliasger K. Salem, Behnoush Khorsand Sourkohi, John E. Femino, Douglas Fredericks
  • Publication number: 20200222559
    Abstract: The present disclosure provides compositions and methods useful for tissue engineering including a composition having chemically modified RNA (cmRNA) encapsulated in or complexed with a non-viral delivery vehicle and a biocompatible, bioresorbable scaffold and methods of using the composition to regenerate, for example, bone tissue.
    Type: Application
    Filed: May 30, 2019
    Publication date: July 16, 2020
    Inventors: Satheesh Elangovan, Sheetal Reginald R. D'mello, Anh-Vu T. Do, Liu Hong, Behnoush Khorsand-Sourkohi, Aliasger K. Salem, Michael Kormann
  • Patent number: 10335498
    Abstract: The present disclosure provides compositions and methods useful for tissue engineering including a composition having chemically modified RNA (cmRNA) encapsulated in or complexed with a non-viral delivery vehicle and a biocompatible, bioresorbable scaffold and methods of using the composition to regenerate, for example, bone tissue.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: July 2, 2019
    Assignee: University of Iowa Research Foundation
    Inventors: Satheesh Elangovan, Sheetal Reginald R D'mello, Anh-Vu T Do, Liu Hong, Behnoush Khorsand-Sourkohi, Aliasger K Salem, Michael Kormann
  • Publication number: 20180000736
    Abstract: A pharmaceutical composition is provided that is useful to enhance the repair of articular cartilage, to treat a joint injury or to prevent, inhibit or treat osteoarthritis in a mammal. The composition may include an effective amount of an isolated protein that is a chemoattractant for chondrogenic progenitor cells and/or an effective amount of an isolated protein that is a chondro genic factor or a nucleic acid sequence that encodes a chondrogenic factor.
    Type: Application
    Filed: January 7, 2016
    Publication date: January 4, 2018
    Inventors: James A. Martin, Yin Yu, Dong Rim Seol, Aliasger K Salem, Behnoush Khorsand Sourkohi, Anh-Vu T Do, Marc Brouillette
  • Publication number: 20160220698
    Abstract: The present disclosure provides compositions and methods useful for tissue engineering.
    Type: Application
    Filed: December 29, 2015
    Publication date: August 4, 2016
    Inventors: Satheesh Elangovan, Sheetal Reginald R. D'mello, Anh-Vu T. Do, Liu Hong, Behnoush Khorsand-Sourkohi, Aliasger K. Salem